NCT03380312 is a clinical trial of rTARUP technique in Hernia, Incisional, sponsored by Filip Muysoms.

Who is sponsoring NCT03380312?

NCT03380312 is sponsored by Filip Muysoms.

What drugs are being tested in NCT03380312?

Interventions in NCT03380312: rTARUP technique.

What condition does NCT03380312 study?

NCT03380312 studies Hernia, Incisional.

Is NCT03380312 still recruiting?

NCT03380312 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT03380312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MRI Imaging of Ipsilateral Retromuscular Access

Completed Last updated 19 September 2024

What this trial tests

trial testing rTARUP technique in Hernia, Incisional in 20 participants. Completed in 19 January 2022.

Timeline

26 September 2017

Primary endpoint
19 June 2021

19 January 2022

Quick facts

Lead sponsor	Filip Muysoms
Status	Completed
Study type	OBSERVATIONAL
Enrollment	20
Start date	26 September 2017
Primary completion	19 June 2021
Estimated completion	19 January 2022
Sites	1 location across Belgium

Drugs / interventions tested

rTARUP technique

Conditions studied

Hernia, Incisional — all drugs for Hernia, Incisional →

Sponsor

Filip Muysoms

Who can join

18 and older, any sex, with Hernia, Incisional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to measure the mesh shrinkage and the visualization of the mesh with MRI scan at 1 month and 13 months after robot assisted retromuscular incisional hernia repair with ipsilateral access and the use of the visible CICAT mesh (Dynamesh®) for defect repair. The investigators also want to measure the volume of the rectus muscles and the change between 1 and 13 months.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prospective cohort study on mesh shrinkage measured with MRI after robot-assisted minimal invasive retrorectus ventral hernia repair using an iron-oxide-loaded polyvinylidene fluoride mesh.
Vierstraete M, Beckers R, Vangeel L, Foriers B, et al · · 2023 · cited 3× · PMID 36854798 · DOI 10.1007/s00464-023-09938-3

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03380312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Filip Muysoms
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03380312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing